This press release is available in French.
Montreal, May 22, 2009 - Canada has received new support to recruit some of its best minds in pediatric leukemia research, thanks to the Cole Foundation. The family foundation has generously pledged $2.5 million to support up-and-coming, Montreal-based researchers at the Universit de Montral, McGill University and the Universit du Qubec's Institut national de la recherche scientifique Institut Armand-Frappier. The Cole Foundation investment will include:
Building on prior investments
This new support builds on the Cole Foundation's Fellowship Programme, which was created to encourage young researchers in search of a cure for pediatric leukemia and related diseases. This year, the Cole Foundation is injecting another $425,000 to propel the work of another 13 Cole Fellows. Since 2007, the Cole Foundation has generously funded some 31 post-doctoral and graduate research fellowships at the three institutions.
"The faculties of medicine at the Universit de Montral and McGill University, along with the Institut Armand-Frappier, produce scientists who are at the forefront of the international battle against pediatric leukemia," said Barry Cole, president of the Cole Foundation. "These new investments, coupled with our ongoing Cole Fellowships, will serve as important tools to empower tomorrow's scientists right here in Montreal so they may find new ways to conquer pediatric leukemia and related diseases."
2009 Cole Fellows
Of the 13 new recipients announced for 2009, 10 will work at Universit de Montral-affiliated institutions such as the Institute for Research in Immunology Cancer (IRIC), Sainte-Justine University Hospital Research Center and Maisonneuve-Rosemont Hospital. At McGill, three Cole Fellows will work from the affiliated McGill University Health Centre and Lady Davis Research Centre of the Jewish General Hospital. The newly announced 2009 Cole Fellows are:
|Contact: Sylvain-Jacques Desjardins|
University of Montreal